Mifepristone Versus Osmotic Dilators in Conjunction With Misoprostol for Cervical Preparation Prior to D&E at 14-19 Weeks

Withdrawn before enrolling · Not applicable

Conditions studied: Legally Induced Abortion Without Mention of Complication

In brief

Dilation and evacuation (D\&E) is a common surgical procedure in the U.S. Adequate pre-operative preparation of the uterine cervix is an important part of preventing complications of the procedure. Traditionally, the uterine cervix is prepared for the procedure using water-attracting dilators, which are placed via a speculum exam and cause discomfort for many women. The objective of this study is to investigate the comparative effectiveness of mifepristone (an oral tablet) versus dilators for cervical preparation for D\&E.

Key facts

Study ID

NCT02679092

Run by

Stanford University

People needed

0

Starts

2016-04-01

Expected to finish

2020-12-01

Last updated by the study team

2019-09-19

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• >18 Years Old
• Viable, Singleton pregnancy
• Voluntarily seeking abortion between 14-19 weeks gestation
• Able to give informed consent and comply with study protocol
• Fluent in English or Spanish

You may not qualify if…

• Allergy to study drugs

Where it is running

• Planned Parenthood Mar Monte — San Jose, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.